Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Innoviva Q4 EPS $0.76 Beats $0.23 Estimate, Sales $85.84M Beat $75.51M Estimate

Author: Happy Mohamed | February 29, 2024 05:29pm
Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.23 by 230.43 percent. This is a 177.55 percent increase over losses of $(0.98) per share from the same period last year. The company reported quarterly sales of $85.84 million which beat the analyst consensus estimate of $75.51 million by 13.68 percent. This is a 30.45 percent increase over sales of $65.80 million the same period last year.

Posted In: INVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist